Production of germline competent chicken cell lines

Information

  • Research Project
  • 6883508
  • ApplicationId
    6883508
  • Core Project Number
    R43GM073306
  • Full Project Number
    1R43GM073306-01
  • Serial Number
    73306
  • FOA Number
  • Sub Project Id
  • Project Start Date
    3/1/2005 - 19 years ago
  • Project End Date
    12/31/2005 - 18 years ago
  • Program Officer Name
    DUGLAS-TABOR, YVONNE
  • Budget Start Date
    3/1/2005 - 19 years ago
  • Budget End Date
    12/31/2005 - 18 years ago
  • Fiscal Year
    2005
  • Support Year
    1
  • Suffix
  • Award Notice Date
    2/14/2005 - 19 years ago

Production of germline competent chicken cell lines

DESCRIPTION (provided by applicant): The aim of this research is to establish a cell line from chicken primordial germ cells that retains it potential to contribute to the germline with the goal of developing genetically modified chickens that produce pharmaceutical proteins in their eggs. Primordial germ cells obtained from the blood and the gonads can be cultured and retain their ability to contribute to the germline when injected into the bloodstream of stage 14-17 chicken embryos. However, only short periods of mixed cultures have been reported and the number of cells that have been generated is too small to be used for the production of transgenic chickens. If PGCs can be cultured and expanded for longer periods of time to achieve stable integration of transgenes while maintaining their competency to colonize the germline, it would provide a novel and reliable route to germline transmission. This application proposes to obtain PGCs from the germinal crescent to obtain a pure population of PGCs and to culture the PGCs under various conditions to obtain a cell line that retains the potential to contribute to the germline after injection into the bloodstream of a stage 14-16 (H&H) embryo.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    114657
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:114657\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ORIGEN THERAPEUTICS
  • Organization Department
  • Organization DUNS
    026167994
  • Organization City
    Emeryville
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    94608
  • Organization District
    UNITED STATES